Biogen Inc Stock Widgets and Gadgets
| BIIB Stock | USD 194.11 0.27 0.14% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- BIIB Biogen Inc
- Latest Gear Up for Biogen Q1 Earnings Wall Street Estimates for Key Metrics
- BIIB 194.11 -0.27
- Low 193.23
- High 196.78
- Alpha -0.47
- Beta 1.38
- Return On Equity 0.0824
- Return On Asset 0.0458
- Profit Margin 0.12 %
- Operating Margin 0.19 %
- Current Valuation 34.59 B
- Shares Outstanding 145.36 M
- Shares Owned By Insiders 0.68 %
- Shares Owned By Institutions 92.98 %
- Number Of Shares Shorted 3.55 M
- Price To Earning 14.83 X
- Price To Book 1.95 X
- Price To Sales 2.93 X
- Revenue 9.84 B
- Gross Profit 7.9 B
- EBITDA 2.6 B
- Net Income 1.16 B
- Cash And Equivalents 4.91 B
- Cash Per Share 34.10 X
- Total Debt 7.34 B
- Debt To Equity 0.52 %
- Current Ratio 2.49 X
- Book Value Per Share 102.14 X
- Cash Flow From Operations 1.55 B
- Short Ratio 2.66 X
- Earnings Per Share 7.96 X
- Price To Earnings To Growth 6.24 X
- Target Price 297.8
- Number Of Employees 7.57 K
- Beta -0.009
- Market Capitalization 28.22 B
- Total Asset 26.84 B
- Retained Earnings 17.63 B
- Working Capital 3.42 B
- Current Asset 8.73 B
- Current Liabilities 3.42 B
- Net Asset 26.84 B
- Accumulation Distribution 0.018
- Daily Balance Of Power (0.08)
- Rate Of Daily Change 1.0
- Day Median Price 195.01
- Day Typical Price 194.71
- Market Facilitation Index 3.55
- Price Action Indicator (1.03)
- Period Momentum Indicator (0.27)
Market Snapshot Widget Example
DAX Index Germany | 17,861 0.70 | |
Taiwan Weighted Taiwan | 19,411 0.59 | |
PSI 20 Stock Portugal | 6,515 3.50 | |
CROBEX Croatia | 2,803 0.14 | |
Budapest SE Hungary | 65,126 0.12 | |
IDX 30 Jakarta Indonesia | 467.48 0.14 | |
ISEQ 20 Price Ireland | 1,646 0.05 | |
NYSE Comp USA | 17,602 0.82 | |
Tel Aviv 35 Israel | 1,912 0.55 | |
Coreshares Index Tracker South Afric | 1,026 0.59 | |
IPC MEXICO Mexico | 56,552 1.23 | |
KL Technology Malaysia | 62.69 0.14 | |
IBEX 35 Index Spain | 10,890 1.50 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,554 0.49 | |
SPASX Dividend Opportunities Australia | 1,655 0.68 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.11 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,290 0.01 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,173 0.06 | |
Basic Materials Brazil | 5,966 0.05 | |
Swiss Leader Price Switzerland | 1,847 0.38 | |
Fondo Mutuo ETF Chile | 1,407 0.21 | |
Athens General Comp Greece | 1,420 1.99 | |
Stock Exchange Of Thailand | 1,350 1.31 | |
PX Prague Stock Czech Repub | 1,551 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,444 0.02 | |
WIG 30 Poland | 3,102 1.72 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Biogen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Biogen
Compare Biogen To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 7.96 | Revenue Per Share 67.972 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0458 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.